It can be concluded that regulation of gene expression, including TAGLN, KRT14, ACTB, APOA1, PRDX2 and HP proteins can play a crucial role in the pathology of Low grade serous ovarian cancer. This evidence concerns the gene PRDX2 and ovarian serous adenocarcinoma.